Cargando…
WS05.04 SARS-CoV-2 infection is reduced in both immortalised and primary CFTR-modulated human bronchial epithelial cells
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Cystic Fibrosis Society.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184780/ http://dx.doi.org/10.1016/S1569-1993(22)00180-1 |
_version_ | 1784724602887340032 |
---|---|
author | Lotti, V. Merigo, F. Lagni, A. Di Clemente, A. Ligozzi, M. Bernardi, P. Rossini, G. Concia, E. Plebani, R. Romano, M. Sbarbati, A. Sorio, C. Gibellini, D. |
author_facet | Lotti, V. Merigo, F. Lagni, A. Di Clemente, A. Ligozzi, M. Bernardi, P. Rossini, G. Concia, E. Plebani, R. Romano, M. Sbarbati, A. Sorio, C. Gibellini, D. |
author_sort | Lotti, V. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9184780 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | European Cystic Fibrosis Society. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91847802022-06-10 WS05.04 SARS-CoV-2 infection is reduced in both immortalised and primary CFTR-modulated human bronchial epithelial cells Lotti, V. Merigo, F. Lagni, A. Di Clemente, A. Ligozzi, M. Bernardi, P. Rossini, G. Concia, E. Plebani, R. Romano, M. Sbarbati, A. Sorio, C. Gibellini, D. J Cyst Fibros Oral Sessions European Cystic Fibrosis Society. 2022-06 2022-06-10 /pmc/articles/PMC9184780/ http://dx.doi.org/10.1016/S1569-1993(22)00180-1 Text en Copyright © 2022 European Cystic Fibrosis Society. All rights reserved. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Oral Sessions Lotti, V. Merigo, F. Lagni, A. Di Clemente, A. Ligozzi, M. Bernardi, P. Rossini, G. Concia, E. Plebani, R. Romano, M. Sbarbati, A. Sorio, C. Gibellini, D. WS05.04 SARS-CoV-2 infection is reduced in both immortalised and primary CFTR-modulated human bronchial epithelial cells |
title | WS05.04 SARS-CoV-2 infection is reduced in both immortalised and primary CFTR-modulated human bronchial epithelial cells |
title_full | WS05.04 SARS-CoV-2 infection is reduced in both immortalised and primary CFTR-modulated human bronchial epithelial cells |
title_fullStr | WS05.04 SARS-CoV-2 infection is reduced in both immortalised and primary CFTR-modulated human bronchial epithelial cells |
title_full_unstemmed | WS05.04 SARS-CoV-2 infection is reduced in both immortalised and primary CFTR-modulated human bronchial epithelial cells |
title_short | WS05.04 SARS-CoV-2 infection is reduced in both immortalised and primary CFTR-modulated human bronchial epithelial cells |
title_sort | ws05.04 sars-cov-2 infection is reduced in both immortalised and primary cftr-modulated human bronchial epithelial cells |
topic | Oral Sessions |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184780/ http://dx.doi.org/10.1016/S1569-1993(22)00180-1 |
work_keys_str_mv | AT lottiv ws0504sarscov2infectionisreducedinbothimmortalisedandprimarycftrmodulatedhumanbronchialepithelialcells AT merigof ws0504sarscov2infectionisreducedinbothimmortalisedandprimarycftrmodulatedhumanbronchialepithelialcells AT lagnia ws0504sarscov2infectionisreducedinbothimmortalisedandprimarycftrmodulatedhumanbronchialepithelialcells AT diclementea ws0504sarscov2infectionisreducedinbothimmortalisedandprimarycftrmodulatedhumanbronchialepithelialcells AT ligozzim ws0504sarscov2infectionisreducedinbothimmortalisedandprimarycftrmodulatedhumanbronchialepithelialcells AT bernardip ws0504sarscov2infectionisreducedinbothimmortalisedandprimarycftrmodulatedhumanbronchialepithelialcells AT rossinig ws0504sarscov2infectionisreducedinbothimmortalisedandprimarycftrmodulatedhumanbronchialepithelialcells AT conciae ws0504sarscov2infectionisreducedinbothimmortalisedandprimarycftrmodulatedhumanbronchialepithelialcells AT plebanir ws0504sarscov2infectionisreducedinbothimmortalisedandprimarycftrmodulatedhumanbronchialepithelialcells AT romanom ws0504sarscov2infectionisreducedinbothimmortalisedandprimarycftrmodulatedhumanbronchialepithelialcells AT sbarbatia ws0504sarscov2infectionisreducedinbothimmortalisedandprimarycftrmodulatedhumanbronchialepithelialcells AT sorioc ws0504sarscov2infectionisreducedinbothimmortalisedandprimarycftrmodulatedhumanbronchialepithelialcells AT gibellinid ws0504sarscov2infectionisreducedinbothimmortalisedandprimarycftrmodulatedhumanbronchialepithelialcells |